Prognostic and Predictive Value of Complete Blood Count Parameters in Patients with NSCLC Treated with PD-1 Inhibitors

被引：0
|
作者：
Tourkantonis, I. [1 ]
Grapsa, D. [1 ]
Charpidou, A. [1 ]
Gkiozos, I. [1 ]
Gogas, H. [2 ]
Psyrri, D. [3 ]
Syrigos, K. [1 ]
机构：
[1] Natl & Kapodistrian Univ Athens, Dept Internal Med 3, Sch Med, Oncol Unit, Athens, Greece
[2] Natl & Kapodistrian Univ Athens, Sch Med, Dept Internal Med 1, Oncol Unit, Athens, Greece
[3] Natl & Kapodistrian Univ Athens, Sch Med, Dept Internal Med 2, Oncol Unit, Athens, Greece
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 03期
关键词：
Advanced non-small cell lung cancer; PD-1; inhibitors; complete blood count parameters;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P33.13
引用
收藏
页码：S410 / S411
页数：2
相关论文
共 50 条
  • [1] Delta-He as a Novel Predictive and Prognostic Biomarker in Patients With NSCLC Treated With PD-1/PD-L1 Inhibitors
    Hong, Green
    Lee, Song-, I
    Kang, Da Hyun
    Chung, Chaeuk
    Park, Hee Sun
    Lee, Jeong Eun
    CANCER MEDICINE, 2025, 14 (07):
  • [2] The Prognostic Value of Gastric Immune Prognostic Index in Gastric Cancer Patients Treated With PD-1/PD-L1 Inhibitors
    Chen, Li
    Zhao, Ruihu
    Sun, Hao
    Huang, Rong
    Pan, Hongming
    Zuo, Yanjiao
    Zhang, Lele
    Xue, Yingwei
    Li, Xingrui
    Song, Hongjiang
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [3] Baseline full blood count parameters as predictors of response to PD-1 inhibition in advanced NSCLC
    Crumbaker, M.
    Carlino, M.
    Hui, R.
    Mersiades, A.
    Gurney, H.
    Todd, J.
    Gao, B.
    Nagrial, A.
    ANNALS OF ONCOLOGY, 2016, 27
  • [4] The Prognostic Value of Peripheral Blood Inflammatory Markers in Hepatocellular Carcinoma Treated with Lenvatinib Combined with PD-1 Inhibitors
    Xin, Yujing
    Liu, Ning
    Peng, Gang
    Huang, Xiaoyu
    Cao, Xiaojing
    Zhou, Xiang
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2025, 12 : 135 - 147
  • [5] Serum CRP Decrease Has Predictive Value for LongTerm Disease Control by PD-1/ PD-L1 Inhibitors in Patients with NSCLC
    Matsuzawa, R.
    Morise, M.
    Tanaka, I.
    Koyama, J.
    Kimura, T.
    Kondoh, Y.
    Hase, T.
    Sakamoto, K.
    Hashimoto, N.
    Hasegawa, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S716 - S716
  • [6] Predictive and prognostic value of preoperative complete blood count in prostate cancer
    Kokenek-Unal, Tuba Dilay
    Findik, Siddika
    JOURNAL OF CLINICAL AND ANALYTICAL MEDICINE, 2018, 9 (06) : 543 - 547
  • [7] Predictive value of tumor mutational burden for PD-1/PD-L1 inhibitors in NSCLC: A meta-analysis
    Li, Wenjie
    Zhao, Yanjun
    Zhang, Hongjun
    Zheng, Wenying
    Wang, Ruixuan
    Gu, Xing
    MEDICINE, 2023, 102 (40) : E34990
  • [8] Predictive and Prognostic Value of CTC Monitoring in Advanced NSCLC Patients Treated with Immune Checkpoint Inhibitors
    Gao, G.
    Li, J.
    Zhou, F.
    Li, W.
    Xiong, A.
    Chen, X.
    Ren, S.
    Zhou, C.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S730 - S730
  • [9] Predictive value of complete blood count parameters for placental invasion anomalies
    Yayla, Cigdem Abide
    Ozkaya, Enis
    Tayyar, Ahter
    Senol, Taylan
    Senturk, M. Baki
    Karateke, Ates
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2017, 30 (19): : 2324 - 2328
  • [10] PD-1 inhibitors cause ILD in NSCLC patients with hypertension
    Reactions Weekly, 2022, 1925 (1) : 11 - 11
12345